Back

High rate of eligibility for subcutaneous implantable cardioverter defibrillator in patients with brugada syndrome

3 May 2019 (15:00 - 16:30)
Organised by:
Congress Presentation Part of: Moderated poster session - Arrhythmias, Frailty and Advanced Practice Arrhythmias, General, Other ACNAP Premium Access EuroHeartCare 2019

About the speaker

Photo
Ms Maira Marino

Salvatore Maugeri Foundation IRCCS, Pavia (Italy)

6 More presentations in this session

Presentation thumbnail
Help me to help myself. Effectiveness of nurse-led educational interventions to patient's self-care in chronic heart failure. A systematic review and meta-analysis.
Doctor A. Massimi (Rome, IT)
Abstract Slides
Presentation thumbnail
Delirium in hospital elders: common, recognized and undiagsnosed
Miss I. Instenes (Bergen, NO)
Abstract
Presentation thumbnail
Development of a questionnaire to assess body image concerns in patients with an implantable cardioverter defibrillator: A qualitative study
Mrs V. Frydensberg (Odense, DK)
Abstract Slides
Presentation thumbnail
Depressive symptoms of patients and their caregivers after an implantation of a left ventricular assist device
Doctor N. Kato (Linkoping, SE)
Abstract
Presentation thumbnail
Validity and Reliability of the Caregiver Contribution to Self-Care Chronic Illness Inventory (CC-SCCII)
Doctor S. Lorini (Rome, IT)
Abstract Slides

Access the full session

Session thumbnail
Moderated poster session - Arrhythmias, Frailty and Advanced Practice

The Event

Event poster

EuroHeartCare 2019

3 May 2019 15:00 CET
You may be interested in
thumbnail
Congress Presentation
Troubleshooting in risk stratification in a concealed arrhythmogenic cardiomyopathy associated with intermitted Brugada syndrome.
3 April 2022
thumbnail
Congress Presentation
Subcutaneous and single-chamber transvenous defibrillators: a nationwide matched control study.
24 April 2021
thumbnail
Congress Presentation
Implantable cardioverter-defibrillator implantation should be considered in high-risk patients with apical hypertrophic cardiomyopathy as the same manner with the septal type
18 April 2023
thumbnail
Congress Session
Subcutaneous implantable cardioverter defibrillator
1 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources